Trisol System EFS Study
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Trisol Medical
- Study ID
- NCT04905017
- Status
- Recruiting
Conditions
- Tricuspid Regurgitation
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Transcatheter Tricuspid Valve Replacement — DEVICEReplacement of the tricusupid valve using Trisol System in a transcatheter approach
Study Details
The objective of this early feasibility study is to gain early clinical insight into Trisol system safety and performance to treat patients with moderate or greater tricuspid regurgitation (TR).
Key Dates
- Start date
- Mar 2, 2022
- Status verified
- Jan 2025
- Primary completion
- Jan 1, 2026
- Completion
- Jul 1, 2031
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Treatment with the Trisol System
Primary Outcome Measure
Rate of device-related serious adverse events [ Time Frame: Up to 30 days ]
Central Contacts
- Ron Davidson, B. Sc., MBA+972 528998866
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | Rajendra Makkar, MD (PRINCIPAL_INVESTIGATOR) |
| Piedmont Heart Institute | Atlanta | Georgia | 30309 | Vinod Thourani, MD (PRINCIPAL_INVESTIGATOR) Pradeep K Yadav, MD (PRINCIPAL_INVESTIGATOR) |
| Columbia University Medical Center/NYPH | New York | New York | 10032 | |
| Cleveland Clinic | Cleveland | Ohio | 44195 | Amar Krishnaswamy, MD (PRINCIPAL_INVESTIGATOR) |
| Main Line Health / Lankenau Institute for Medical Research | Wynnewood | Pennsylvania | 19096 | William Gray, MD FACC FSCAI (PRINCIPAL_INVESTIGATOR) |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37203 | Kashish Goel, MD (PRINCIPAL_INVESTIGATOR) |
| University of Virginia Cardiology | Charlottesville | Virginia | 22908 |
Find similar trials in Los Angeles, CA
By research site
Related Studies
- Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical TrialRecruiting · Edwards Lifesciences · Phoenix, Arizona
- TTVR Early Feasibility StudyRecruiting · Medtronic Cardiovascular · Birmingham, Alabama
- Outcome of Patients With Severe Functional TR According to Medical, Transcatheter or Surgical TreatmentEnrolling By Invitation · Ottawa Heart Institute Research Corporation · Rochester, Minnesota
- Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)Recruiting · VDyne, Inc. · Los Angeles, California